Codice QR

Adaptive bridging radiation therapy for relapsed/refractory B-cell lymphoma patient undergoing CAR T-cell therapy: Case report

Radiation therapy (RT) is utilized as a bridging strategy for patients with aggressive B-cell lymphoma prior to CD19-targeted chimeric antigen receptor (CAR T)-cell therapy. RT has been shown to provide local control without exacerbating the toxicities associated with subsequent CAR T-cell infusion....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Hazim S. Ababneh, P. Connor Johnson, Jennifer Pursley, Chirayu G. Patel
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2024-09-01
Serie:Clinical and Translational Radiation Oncology
Soggetti:
Accesso online:http://www.sciencedirect.com/science/article/pii/S2405630824001095
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!